Scarica l'app Stockscreener
27.58
0.58%
-0.13
Precedente Chiudi:
$27.71
Aprire:
$27.34
Volume 24 ore:
785.77K
Relative Volume:
0.62
Capitalizzazione di mercato:
$1.87B
Reddito:
$2.74B
Utile/perdita netta:
$-441.40M
Rapporto P/E:
-4.2171
EPS:
-6.54
Flusso di cassa netto:
$13.00M
1 W Prestazione:
-2.27%
1M Prestazione:
-8.11%
6M Prestazione:
-5.39%
1 anno Prestazione:
-29.52%
Intervallo 1D:
$26.79
$27.98
Intervallo di 1 settimana:
$26.17
$28.63
Portata 52W:
$22.05
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Nome
Quidelortho Corporation
Settore
Industria
Telefono
(858) 552-1100
Indirizzo
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Confronta QDEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
27.55 | 1.88B | 2.74B | -441.40M | 13.00M | -6.54 |
|
ABT
Abbott Laboratories
|
125.36 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.51 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.73 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.14 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.11 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-09-19 | Ripresa | UBS | Neutral |
| 2024-09-05 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2024-03-04 | Downgrade | UBS | Neutral → Sell |
| 2024-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-14 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-19 | Iniziato | Citigroup | Neutral |
| 2022-07-20 | Iniziato | UBS | Sell |
| 2022-06-17 | Ripresa | JP Morgan | Neutral |
| 2022-02-22 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-03-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Reiterato | Barclays | Overweight |
| 2018-01-04 | Aggiornamento | CL King | Neutral → Buy |
| 2017-09-19 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Reiterato | Canaccord Genuity | Hold |
| 2017-02-17 | Iniziato | CL King | Neutral |
| 2016-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Reiterato | Barclays | Overweight |
| 2016-02-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-12-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Iniziato | Barclays | Overweight |
| 2013-07-31 | Reiterato | Canaccord Genuity | Buy |
| 2011-03-03 | Downgrade | Wedbush | Outperform → Neutral |
Mostra tutto
Quidelortho Corporation Borsa (QDEL) Ultime notizie
QuidelOrtho (QDEL): Assessing Valuation After FDA Clearance for High-Sensitivity Troponin I Assay - simplywall.st
US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay - Pharmabiz.com
How to build a dashboard for QuidelOrtho Corporation stock2025 Key Lessons & Free Accurate Trade Setup Notifications - newser.com
Can QuidelOrtho Corporation stock deliver surprise earnings beatMarket Activity Recap & Risk Managed Trade Strategies - newser.com
Is QuidelOrtho Corporation trending in predictive chart modelsEarnings Recap Report & Fast Entry Momentum Alerts - newser.com
Will QuidelOrtho Corporation benefit from macro trendsJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
Published on: 2025-11-04 00:39:36 - newser.com
Analyzing drawdowns of QuidelOrtho Corporation with statistical toolsQuarterly Trade Report & Daily Oversold Stock Bounce Ideas - newser.com
QuidelOrtho receives FDA clearance for high-sensitivity troponin test By Investing.com - Investing.com India
What candlestick patterns are forming on QuidelOrtho Corporation2025 Technical Patterns & Free Community Consensus Stock Picks - newser.com
QuidelOrtho (QDEL) Q3 Earnings: What To Expect - Yahoo! Finance Australia
Craig-Hallum Maintains QuidelOrtho(QDEL.US) With Buy Rating - 富途牛牛
QuidelOrtho Gets FDA Clearance for Cardiac Assay - MarketScreener
QuidelOrtho Corporation’s volatility index tracking explainedRate Cut & High Win Rate Trade Tips - newser.com
Will QuidelOrtho Corporation stock reach Wall Street targetsJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Predicting QuidelOrtho Corporation trend using moving averages2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Is QuidelOrtho Corporation stock near bottom after declineWeekly Trade Analysis & Fast Gaining Stock Reports - newser.com
Quidelortho receives FDA 510(k) clearance for VITROS Immunodiagnostic Products hs Troponin I assay - MarketScreener
Analyzing recovery setups for QuidelOrtho Corporation investorsJuly 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Will QuidelOrtho Corporation stock split attract more investorsJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
Real time scanner hits for QuidelOrtho Corporation explainedWeekly Trend Recap & Long-Term Safe Investment Plans - newser.com
QuidelOrtho receives FDA clearance for high-sensitivity troponin test - Investing.com
What technical models suggest about QuidelOrtho Corporation’s comebackOptions Play & Weekly Return Optimization Plans - newser.com
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay - PR Newswire
Published on: 2025-11-03 04:51:46 - newser.com
Why QuidelOrtho Corporation stock remains on watchlists2025 Market Trends & Long-Term Growth Stock Strategies - newser.com
Volume spikes in QuidelOrtho Corporation stock – what they mean2025 Fundamental Recap & AI Driven Stock Reports - newser.com
Is QuidelOrtho Corporation (QL1A) stock a momentum leaderStop Loss & Weekly Top Stock Performers List - newser.com
Will QuidelOrtho Corporation stock benefit from infrastructure spendingQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
QuidelOrtho Faces Critical Earnings Test Amid Diverging Analyst Views - AD HOC NEWS
Will QuidelOrtho Corporation stock recover faster than marketPrice Action & Daily Stock Momentum Reports - newser.com
Is QuidelOrtho Corporation (QL1A) stock undervalued at current price2025 Retail Activity & Real-Time Volume Triggers - newser.com
Regression analysis insights on QuidelOrtho Corporation performanceEarnings Recap Summary & Smart Money Movement Alerts - newser.com
Published on: 2025-11-02 01:25:49 - newser.com
How hedge fund analytics apply to QuidelOrtho Corporation stock2025 Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Brighton Jones LLC Makes New $384,000 Investment in QuidelOrtho Corporation $QDEL - MarketBeat
Is QuidelOrtho Corporation (QL1A) stock testing key supportEarnings Summary Report & Risk Managed Investment Signals - newser.com
Quidelortho Corporation Azioni (QDEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.86%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):